Profile | GDS4284 / 1552703_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 2287.41 | 85 |
GSM687648 | Patient 402 control | 3576.34 | 90 |
GSM687653 | Patient 403 control | 2966.81 | 88 |
GSM687658 | Patient 404 control | 7755.78 | 96 |
GSM687663 | Patient 411 control | 4108.57 | 92 |
GSM687668 | Patient 422 control | 3979.64 | 91 |
GSM687673 | Patient 424 control | 5635.96 | 94 |
GSM687678 | Patient 425 control | 4212.66 | 92 |
GSM687683 | Patient 427 control | 5419.51 | 94 |
GSM687688 | Patient 428 control | 2577.13 | 87 |
GSM687695 | Patient 441 control | 9932.45 | 97 |
GSM687699 | Patient 443 control | 5062.41 | 94 |
GSM687704 | Patient 444 control | 3475.39 | 90 |
GSM687707 | Patient 448 control | 4444.59 | 92 |
GSM687712 | Patient 449 control | 3929.37 | 91 |
GSM687719 | Patient 450 control | 8412.02 | 96 |
GSM687724 | Patient 451 control | 3566.77 | 91 |
GSM687728 | Patient 452 control | 7503.05 | 96 |
GSM687646 | Patient 401 treated 24h | 2797.94 | 88 |
GSM687649 | Patient 402 treated 24h | 3537.6 | 90 |
GSM687665 | Patient 411 treated 24h | 4370.43 | 92 |
GSM687651 | Patient 402 treated 4 weeks | 3879.09 | 91 |
GSM687667 | Patient 411 treated 4 weeks | 3489.25 | 90 |
GSM687670 | Patient 422 treated 24h | 4841.72 | 93 |
GSM687671 | Patient 422 treated 4 weeks | 3383.42 | 90 |
GSM687654 | Patient 403 treated 24h | 3347.31 | 90 |
GSM687675 | Patient 424 treated 24h | 5265.07 | 94 |
GSM687685 | Patient 427 treated 24h | 4123.5 | 92 |
GSM687656 | Patient 403 treated 4 weeks | 2675.4 | 87 |
GSM687677 | Patient 424 treated 4 weeks | 4919.48 | 93 |
GSM687687 | Patient 427 treated 4 weeks | 3584.53 | 90 |
GSM687692 | Patient 428 treated 4h | 3452.37 | 90 |
GSM687716 | Patient 449 treated 4h | 3000.32 | 89 |
GSM687722 | Patient 450 treated 4h | 7380.59 | 96 |
GSM687680 | Patient 425 treated 24h | 3348.26 | 90 |
GSM687690 | Patient 428 treated 24h | 3125.33 | 89 |
GSM687700 | Patient 443 treated 24h | 9463.86 | 97 |
GSM687705 | Patient 444 treated 24h | 5361.55 | 94 |
GSM687714 | Patient 449 treated 24h | 3951.35 | 91 |
GSM687721 | Patient 450 treated 24h | 9028.87 | 97 |
GSM687682 | Patient 425 treated 4 weeks | 3588.17 | 90 |
GSM687694 | Patient 428 treated 4 weeks | 3224.58 | 89 |
GSM687702 | Patient 443 treated 4 weeks | 4914.25 | 93 |
GSM687718 | Patient 449 treated 4 weeks | 4158.12 | 92 |
GSM687723 | Patient 450 treated 4 weeks | 5411.7 | 94 |
GSM687661 | Patient 404 treated 4h | 7626.37 | 96 |
GSM687710 | Patient 448 treated 4h | 4388.47 | 92 |
GSM687726 | Patient 451 treated 4h | 3135.27 | 89 |
GSM687730 | Patient 452 treated 4h | 3416.92 | 91 |
GSM687660 | Patient 404 treated 24h | 35572.9 | 99 |
GSM687697 | Patient 441 treated 24h | 13034 | 98 |
GSM687709 | Patient 448 treated 24h | 5547.6 | 94 |
GSM687725 | Patient 451 treated 24h | 4148.79 | 92 |
GSM687729 | Patient 452 treated 24h | 16682.8 | 98 |
GSM687727 | Patient 451 treated 4 weeks | 3445.04 | 90 |
GSM687731 | Patient 452 treated 4 weeks | 7833.28 | 96 |